Gustavo Pesquin

Gustavo Pesquin serves as Chief Executive Officer at Asklepios BioPharmaceutical, Inc. - (AskBio). Asklepios BioPharmaceutical, Inc. - (AskBio) operates in the research sector with approximately 510.0 employees. The company is headquartered in New York, New York. Asklepios BioPharmaceutical, Inc. - (AskBio) generates annual revenue of 9000000.0. To date, Asklepios BioPharmaceutical, Inc. - (AskBio) has raised 252850854.0 in total funding, with the most recent round being Other.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • 6,952 executive contacts are available in New York.
• • Our database includes 201,469 c suite-level executives.

Outlook GoDaddy Hosting Amazon AWS Mobile Friendly Google Analytics WordPress.org Google Font API Workday Recruit Google Tag Manager Nginx YouTube Remote

aav adenoassociated virus gene therapy rare disease aav manufacturing molecular medicine nucleic acid epigenome doggybone dna biotechnology research aav technology clinical trials genetic diseases therapeutic pipeline orphan drug designation patient advocacy fda approvals muscular dystrophy neuromuscular disorders cns disorders pompe disease parkinson's disease metabolic diseases cardiovascular diseases investigational treatments rare diseases gene therapy clinical development patient-centered approach biomanufacturing capsid library synthetic promoters research collaborations genetic medicine neurodegenerative diseases adnoviruses monogenic disorders leadership team biotherapy therapeutic gene delivery genome editing disease-modifying therapies pharmaceutical partners patient care clinical development research & development technology platform genetic breakthroughs genetic predisposition innovative therapeutics healthcare innovation life sciences biopharmaceuticals market authorization vaccine technology scientific expertise clinical outcomes biotech industry personalized medicine adeno-associated virus clinical-stage genetic disorders neuromuscular diseases central nervous system huntington's disease limb-girdle muscular dystrophy innovative science transformative therapeutics proprietary technology pro10 cell line gene therapy pipeline regulatory designations collaborations bayer ag subsidiary patient-centric advanced therapies transformative molecular medicines therapeutic advancements biotechnology patient demographics unmet medical needs health care health wellness & fitness hospital & health care

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

AD

Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

How can I contact Gustavo Pesquin?

Gustavo Pesquin's verified email address is available on MessageCEO. They currently work at Asklepios BioPharmaceutical, Inc. - (AskBio). Pro subscribers can access direct email addresses for over 200,000 executives.

What company does Gustavo Pesquin lead?

Gustavo Pesquin is Chief Executive Officer at Asklepios BioPharmaceutical, Inc. - (AskBio), a company in the research sector with 510.0 employees. The company is based in New York, New York.

What industry is Gustavo Pesquin in?

Gustavo Pesquin works in the research industry as Chief Executive Officer at Asklepios BioPharmaceutical, Inc. - (AskBio). MessageCEO provides verified contact information for executives across all major industries.

Is Gustavo Pesquin's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Gustavo Pesquin's profile is kept up-to-date with the latest available information.

Last updated: April 12, 2026